EPSILOGEN LTD
Company number 10295520 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£60,990,354
Balance sheet as at 2025-12-31
What it does
The principal activity of the Company continued to be that of an immuno-oncology drug development company focused on the development of IgE antibody drugs. D
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2016-07-26
- Employees
- 22 (2025 accounts · was 21 in 2024)
- Registered office
- Waterfront, Arc West London Manbre Road, Hammersmith, London, United Kingdom, W6 9RH
- Postcode
- W6 9RH
- Capital
- 12 GBP
- Accounts category
- Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-07-13
- Next due by
- 2027-07-27
Nature of business (SIC)
- 72190 Other research and experimental development on natural sciences and engineering
Officers 6 current · 5 resigned
Group structure
Controlled by EPIDAREX CAPITAL II, LP — since 2017-06-26
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZB599221 (Tier 1), registered since 2023.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- epsilogen.com
Previous company names
| Name | Date changed |
|---|---|
| IGEM THERAPEUTICS LIMITED | 2020-04-17 |
Previous registered addresses 2
| Address | Changed on |
|---|---|
| 119 THE HUB 300, KENSAL ROAD, LONDON, W10 5BE, ENGLAND | 2018-05-03 |
| C/O C/O PENNINGTONS MANCHES LLP, APEX PLAZA FORBURY ROAD, READING, RG1 1AX, UNITED KINGDOM | 2017-06-16 |
Among its peers
Top 5%
by shareholders' funds, of 153 similar companies in W
Among the biggest employers among its local peers (22 staff).
Trading since 2016.
Competitors London
-
5. GAUSSION LTD
This company ranks 2 among other research and experimental development on natural sciences and engineering in London.
The class of 2016
28%
of the 564 companies in this sector incorporated in 2016 are still active today; 68% have since been dissolved.
A fact about the year, not a forecast for this company.